Poseida Therapeutics, Inc. Comprehensive Income
Poseida Therapeutics, Inc. reported Comprehensive Income of $20.69 million for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-07.
Financial Statements › Income Statement
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2024-11-07
- Poseida Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-09-30 was $20.69M.
- Poseida Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-06-30 was -$31.41M.
- Poseida Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2024-03-31 was -$24.45M.
- Poseida Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2023-12-31 was -$25.02M.
- Poseida Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$123.16M.
- Poseida Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$64.15M.
- Poseida Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2021 was -$124.98M.
- Poseida Therapeutics, Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2020 was -$129.79M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month |
|---|---|---|---|---|
| 2024-09-30 | $20.69M 10-Q · filed 2024-11-07 | -$10.71M derived: sum of 2 quarters · filed 2024-11-07 | -$35.16M 10-Q · filed 2024-11-07 | -$60.18M derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-06-30 | -$31.41M 10-Q · filed 2024-08-05 | -$55.85M 10-Q · filed 2024-08-05 | -$80.88M derived: sum of 3 quarters · filed 2024-08-05 | -$112.57M derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-03-31 | -$24.45M 10-Q · filed 2024-05-14 | -$49.47M derived: sum of 2 quarters · filed 2024-05-14 | -$81.17M derived: sum of 3 quarters · filed 2024-11-07 | -$108.91M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-12-31 | -$25.02M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | -$56.72M derived: sum of 2 quarters · filed 2024-11-07 | -$84.46M derived: sum of 3 quarters · filed 2024-11-07 | -$123.16M 10-K · filed 2024-03-07 |
| 2023-09-30 | -$31.70M 10-Q · filed 2024-11-07 | -$59.44M derived: sum of 2 quarters · filed 2024-11-07 | -$98.13M 10-Q · filed 2024-11-07 | -$131.46M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | -$27.74M 10-Q · filed 2024-08-05 | -$66.43M 10-Q · filed 2024-08-05 | -$99.76M derived: sum of 3 quarters · filed 2024-08-05 | -$29.36M derived: sum of 4 quarters · filed 2024-08-05 |
| 2023-03-31 | -$38.70M 10-Q · filed 2024-05-14 | -$72.02M derived: sum of 2 quarters · filed 2024-05-14 | -$1.62M derived: sum of 3 quarters · filed 2024-05-14 | -$44.79M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | -$33.32M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $37.07M derived: sum of 2 quarters · filed 2024-03-07 | -$6.09M derived: sum of 3 quarters · filed 2024-03-07 | -$64.15M 10-K · filed 2024-03-07 |
| 2022-09-30 | $70.40M 10-Q · filed 2023-11-09 | $27.23M derived: sum of 2 quarters · filed 2023-11-09 | -$30.83M 10-Q · filed 2023-11-09 | -$29.36M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$43.17M 10-Q · filed 2023-08-08 | -$101.22M 10-Q · filed 2023-08-08 | -$99.76M derived: sum of 3 quarters · filed 2023-08-08 | -$142.18M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | -$58.06M 10-Q · filed 2023-05-09 | -$56.59M derived: sum of 2 quarters · filed 2023-05-09 | -$99.01M derived: sum of 3 quarters · filed 2023-05-09 | -$144.73M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$40.96M derived: sum of 2 quarters · filed 2023-03-09 | -$86.67M derived: sum of 3 quarters · filed 2023-03-09 | -$124.98M 10-K · filed 2023-03-09 |
| 2021-09-30 | -$42.42M 10-Q · filed 2022-11-10 | -$88.14M derived: sum of 2 quarters · filed 2022-11-10 | -$126.45M 10-Q · filed 2022-11-10 | -$162.55M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | -$45.72M 10-Q · filed 2022-08-11 | -$84.02M 10-Q · filed 2022-08-11 | -$120.13M derived: sum of 3 quarters · filed 2022-08-11 | -$154.60M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$38.30M 10-Q · filed 2022-05-12 | -$74.41M derived: sum of 2 quarters · filed 2022-05-12 | -$108.88M derived: sum of 3 quarters · filed 2022-05-12 | -$139.42M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | -$36.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | -$70.58M derived: sum of 2 quarters · filed 2022-03-10 | -$101.11M derived: sum of 3 quarters · filed 2022-03-10 | -$129.79M 10-K · filed 2022-03-10 |
| 2020-09-30 | -$34.47M 10-Q · filed 2021-11-09 | -$65.01M derived: sum of 2 quarters · filed 2021-11-09 | -$93.69M 10-Q · filed 2021-11-09 | -$117.28M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | -$30.54M 10-Q · filed 2021-08-12 | -$59.21M 10-Q · filed 2021-08-12 | -$82.80M derived: sum of 3 quarters · filed 2021-08-12 | -$103.76M derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | -$28.67M 10-Q · filed 2021-05-11 | -$52.26M derived: sum of 2 quarters · filed 2021-05-11 | -$73.23M derived: sum of 3 quarters · filed 2021-05-11 | -$101.85M derived: sum of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | -$23.59M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | -$44.55M derived: sum of 2 quarters · filed 2021-03-11 | -$73.17M derived: sum of 3 quarters · filed 2021-03-11 | -$86.51M 10-K · filed 2021-03-11 |
| 2019-09-30 | -$20.96M 10-Q · filed 2020-11-12 | -$49.58M derived: sum of 2 quarters · filed 2020-11-12 | -$62.92M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | -$28.62M 10-Q · filed 2020-08-20 | -$41.96M 10-Q · filed 2020-08-20 |